Banque Cantonale Vaudoise’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,000
| Closed | -$4K | – | 868 |
|
2024
Q2 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 956 |
|
2024
Q1 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 959 |
|
2023
Q4 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 988 |
|
2023
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1167 |
|
2023
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 1162 |
|
2023
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 1160 |
|
2022
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 1154 |
|
2022
Q3 | $4K | Sell |
1,000
-2,000
| -67% | -$8K | ﹤0.01% | 1186 |
|
2022
Q2 | $9K | Hold |
3,000
| – | – | ﹤0.01% | 1180 |
|
2022
Q1 | $17K | Hold |
3,000
| – | – | ﹤0.01% | 1148 |
|
2021
Q4 | $27K | Hold |
3,000
| – | – | ﹤0.01% | 1141 |
|
2021
Q3 | $32K | Hold |
3,000
| – | – | ﹤0.01% | 1088 |
|
2021
Q2 | $47K | Hold |
3,000
| – | – | ﹤0.01% | 1037 |
|
2021
Q1 | $48K | Buy |
3,000
+1,000
| +50% | +$16K | ﹤0.01% | 990 |
|
2020
Q4 | $42K | Buy |
2,000
+1,400
| +233% | +$29.4K | ﹤0.01% | 948 |
|
2020
Q3 | $9K | Buy |
+600
| New | +$9K | ﹤0.01% | 1010 |
|